Medmira Stock Fundamentals
| MIR Stock | CAD 0.08 0.01 6.67% |
MedMira fundamentals help investors to digest information that contributes to MedMira's financial success or failures. It also enables traders to predict the movement of MedMira Stock. The fundamental analysis module provides a way to measure MedMira's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MedMira stock.
At this time, MedMira's Selling General Administrative is fairly stable compared to the past year. Selling And Marketing Expenses is likely to climb to about 216.8 K in 2024, whereas Total Revenue is likely to drop slightly above 472.5 K in 2024. MedMira | Select Account or Indicator |
MedMira Company Operating Margin Analysis
MedMira's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current MedMira Operating Margin | (7.40) % |
Most of MedMira's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MedMira is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
MedMira Operating Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for MedMira is extremely important. It helps to project a fair market value of MedMira Stock properly, considering its historical fundamentals such as Operating Margin. Since MedMira's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of MedMira's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of MedMira's interrelated accounts and indicators.
Click cells to compare fundamentals
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
MedMira Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, MedMira has an Operating Margin of -7.3956%. This is 78.92% lower than that of the Biotechnology sector and 93.4% lower than that of the Health Care industry. The operating margin for all Canada stocks is 34.22% higher than that of the company.
MedMira Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining MedMira's current stock value. Our valuation model uses many indicators to compare MedMira value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MedMira competition to find correlations between indicators driving MedMira's intrinsic value. More Info.MedMira is considered to be number one stock in return on asset category among its peers. It is regarded third in operating margin category among its peers . At this time, MedMira's Operating Profit Margin is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MedMira's earnings, one of the primary drivers of an investment's value.MedMira Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MedMira's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MedMira could also be used in its relative valuation, which is a method of valuing MedMira by comparing valuation metrics of similar companies.MedMira is currently under evaluation in operating margin category among its peers.
MedMira Current Valuation Drivers
We derive many important indicators used in calculating different scores of MedMira from analyzing MedMira's financial statements. These drivers represent accounts that assess MedMira's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of MedMira's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 276.5M | 79.0M | 88.5M | 62.8M | 56.5M | 33.0M | |
| Enterprise Value | 288.0M | 92.8M | 96.7M | 72.0M | 64.8M | 39.9M |
MedMira Fundamentals
| Return On Asset | -0.26 | ||||
| Operating Margin | (7.40) % | ||||
| Current Valuation | 58.57 M | ||||
| Shares Outstanding | 701.73 M | ||||
| Shares Owned By Insiders | 68.95 % | ||||
| Number Of Shares Shorted | 979 | ||||
| Price To Earning | (5.00) X | ||||
| Price To Sales | 146.45 X | ||||
| Revenue | 432.53 K | ||||
| Gross Profit | (512.51 K) | ||||
| EBITDA | (1.58 M) | ||||
| Net Income | (2.68 M) | ||||
| Cash And Equivalents | 1.06 K | ||||
| Total Debt | 9.27 M | ||||
| Current Ratio | 0.02 X | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (1.27 M) | ||||
| Short Ratio | 0.02 X | ||||
| Earnings Per Share | (0.01) X | ||||
| Beta | 10.73 | ||||
| Market Capitalization | 56.14 M | ||||
| Total Asset | 3.65 M | ||||
| Retained Earnings | (97.96 M) | ||||
| Working Capital | (14.03 M) | ||||
| Net Asset | 3.65 M |
About MedMira Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MedMira's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MedMira using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MedMira based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 862.4 K | 507.5 K | |
| Total Revenue | 497.4 K | 472.5 K | |
| Cost Of Revenue | 118.9 K | 113 K | |
| Stock Based Compensation To Revenue | 0.03 | 0.05 | |
| Sales General And Administrative To Revenue | 2.24 | 2.11 | |
| Research And Ddevelopement To Revenue | 1.25 | 1.50 | |
| Ebit Per Revenue | (4.05) | (4.25) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for MedMira Stock Analysis
When running MedMira's price analysis, check to measure MedMira's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedMira is operating at the current time. Most of MedMira's value examination focuses on studying past and present price action to predict the probability of MedMira's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedMira's price. Additionally, you may evaluate how the addition of MedMira to your portfolios can decrease your overall portfolio volatility.